Suppr超能文献

奥施康定与对乙酰氨基酚联合应用的镇痛浓度——腹腔镜胆囊切除术成年患者的剂量探索研究。

The analgesic concentration of oxycodone with co-administration of paracetamol -- a dose-finding study in adult patients undergoing laparoscopic cholecystectomy.

机构信息

Department of Anaesthesia and Operative Services, Kuopio University Hospital, Kuopio, Finland.

出版信息

Basic Clin Pharmacol Toxicol. 2012 Dec;111(6):391-5. doi: 10.1111/j.1742-7843.2012.00916.x. Epub 2012 Jul 21.

Abstract

We have previously shown that paracetamol has an opioid-sparing effect in tonsillectomy, and now, we evaluated the analgesic efficacy of paracetamol i.v. in early post-operative pain after laparoscopic cholecystectomy (LCC). Twenty-four patients with LCC were randomized to receive paracetamol i.v. 1 g (group 1) or 2 g (group 2) at the end of surgery. All patients were provided 0.1 mg/kg of oxycodone i.v. 15 min. before the end of surgery. At the recovery room when the wound pain at rest was ≥ 3/10 and/or ≥ 5/10 during the wound compression, plasma sample was taken for the determination of oxycodone (minimum effective concentration, MEC), its metabolites and paracetamol. After that the patients were titrated with further doses of oxycodone i.v. to wound pain < 3/10 at rest and < 5/10 during wound compression, plasma sample was taken for the determination of minimum effective analgesic concentration (MEAC) of oxycodone. The total oxycodone dose needed for pain relief was similar, about 0.3 mg/kg (range 0.2-0.5), in both groups (p = 0.80). At the onset of pain, P-oxycodone (MEC) was similar in both groups, 25 ng/ml (19-32) in group 1 and 24 ng/ml (16-34) in group 2. The pain relief (MEAC) was achieved in group 1 with P-oxycodone 70 ng/ml (30-131) and in group 2 with 62 ng/ml (36-100) (p = 0.48). In conclusion, in the early-phase after LCC, there was no significant difference between the effect of paracetamol doses of 1 g and 2 g i.v. on the need of i.v. oxycodone.

摘要

我们之前已经证明,对乙酰氨基酚在扁桃体切除术中具有阿片类药物的节省作用,现在,我们评估了静脉内给予对乙酰氨基酚在腹腔镜胆囊切除术(LCC)后早期术后疼痛中的镇痛效果。24 例接受 LCC 的患者随机分为两组,在手术结束时分别静脉内给予 1 克(组 1)或 2 克(组 2)对乙酰氨基酚。所有患者在手术结束前 15 分钟内静脉内给予 0.1 毫克/公斤羟考酮。在恢复室,当静息时伤口疼痛≥3/10 和/或伤口按压时≥5/10 时,采集血浆样本以测定羟考酮(最小有效浓度,MEC)、其代谢物和对乙酰氨基酚。之后,根据伤口静息疼痛<3/10 和伤口按压时<5/10 的情况,给予患者静脉内滴定进一步剂量的羟考酮,以确定羟考酮的最小有效镇痛浓度(MEAC)。两组患者缓解疼痛所需的总羟考酮剂量相似,约为 0.3 毫克/公斤(范围 0.2-0.5)(p=0.80)。在疼痛开始时,两组患者的 P-羟考酮(MEC)相似,组 1 为 25ng/ml(19-32),组 2 为 24ng/ml(16-34)。组 1 患者的疼痛缓解(MEAC)需要 P-羟考酮 70ng/ml(30-131),组 2 患者需要 62ng/ml(36-100)(p=0.48)。总之,在 LCC 后早期,静脉内给予 1 克和 2 克对乙酰氨基酚对静脉内给予羟考酮的需求没有显著差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验